Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duke University
Prospective phase I study designed to determine the maximum tolerated dose of radiation therapy given in an accelerated fashion (2 Gy/fraction, 6 fractions/week) with concurrent chemotherapy. Intensity-modulated radiation therapy (IMRT) will be utilized to spare the esophagus. All patients on the dose escalation study will participate in additional assessments evaluating esophageal motion and esophageal toxicity from radiation therapy.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologic documentation of one of the following thoracic malignancies:
* Non-small cell lung cancer (stage III or X (recurrent) with disease confined to local/regional sites)
* Small cell lung cancer (stage II-III)
* Thymoma (unresectable)
* Thymic carcinoma (unresectable)
Eastern Cooperative Oncology Group (ECOG) performance status 0-1
Weight loss \< 10% in preceding 3 months prior to diagnosis
ANC \> or = 1500 and platelet count \> or = 100,000.
Creatinine clearance greater than 50 ml/min
18 years of age or older.
Negative pregnancy test in women of child-bearing potential